South Texas Accelerated Research Therapeutics

901 papers and 22.6k indexed citations i.

About

In recent decades, authors affiliated with South Texas Accelerated Research Therapeutics have published 901 papers, which have received a total of 22.6k indexed citations. Scholars at this organization have produced 551 papers in Oncology, 268 papers in Molecular Biology and 257 papers in Pulmonary and Respiratory Medicine on the topics of Cancer Immunotherapy and Biomarkers (229 papers), Lung Cancer Treatments and Mutations (111 papers) and HER2/EGFR in Cancer Research (97 papers). Their work is cited by papers focused on Oncology (11.8k citations), Molecular Biology (8.9k citations) and Pulmonary and Respiratory Medicine (5.1k citations). Authors at South Texas Accelerated Research Therapeutics collaborate with scholars in United States, Spain and Australia and have published in prestigious journals including Nature, Proceedings of the National Academy of Sciences and Nature Genetics. Some of South Texas Accelerated Research Therapeutics's most productive authors include Anthony W. Tolcher, Amita Patnaik, Kyriakos P. Papadopoulos, Antoni Ribas, Drew Rasco, Jonathan E. Zuckerman, Mark E. Davis, Yun Yen, Jeremy D. Heidel and David B. Seligson.

In The Last Decade

Fields of papers published by authors at South Texas Accelerated Research Therapeutics

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with South Texas Accelerated Research Therapeutics at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with South Texas Accelerated Research Therapeutics at the time of their publication.

Countries citing scholars working at South Texas Accelerated Research Therapeutics

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at South Texas Accelerated Research Therapeutics. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at South Texas Accelerated Research Therapeutics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites South Texas Accelerated Research Therapeutics more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025